Vx-950 and Neurontin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vx-950 (telaprevir) and Neurontin (gabapentin). Common drug interactions include dyspnoea among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Vx-950 and Neurontin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Vx-950?
Vx-950 has active ingredients of telaprevir. eHealthMe is studying from 9,465 Vx-950 users. Check the latest studies of Vx-950.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
17 people who take Vx-950 and Neurontin together, and have interactions are studied.

What are the common drug interactions of Vx-950 and Neurontin, by gender? *:
female:
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Anaemia (lack of blood)
- Decreased appetite
- Depression
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Rash
- Haemoglobin decreased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
male:
- Diarrhoea
- Fatigue (feeling of tiredness)
- Eye pain
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Headache (pain in head)
- Injection site bruising
- Injection site erythema (redness at injection site)
- Nausea (feeling of having an urge to vomit)
- Neck pain
- Ocular hyperaemia (an abnormally large amount of blood in eye)
What are the common drug interactions of Vx-950 and Neurontin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Dizziness postural
- Haemoglobin decreased
- Hypertension (high blood pressure)
- Hyperuricaemia (level of uric acid in the blood that is abnormally high)
- Injection site mass
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Platelet count decreased
- Pyrexia (fever)
- Rash
40-49:
- Anaemia (lack of blood)
- Dysgeusia (disorder of the sense of taste)
- Dyspnoea (difficult or laboured respiration)
- Influenza like illness
- Rash macular (small, flat red spots)
50-59:
- Abdominal pain
- Agitation (state of anxiety or nervous excitement)
- Anaemia (lack of blood)
- Asthenia (weakness)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Constipation
- Decreased appetite
- Depression
- Diarrhoea
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
60+:
- Rash
- Anaemia (lack of blood)
- Hepatic steatosis (fatty liver disease)
- Influenza like illness
- Lung neoplasm malignant (cancer tumour of lung)
- Nausea (feeling of having an urge to vomit)
- Neck pain
- Decreased appetite
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
What are the existing conditions these people have? *
- Hepatitis C: 14 people, 82.35%
- Depression: 4 people, 23.53%
- High Blood Pressure: 2 people, 11.76%
- Type 2 Diabetes: 1 person, 5.88%
- Stress And Anxiety: 1 person, 5.88%
- Diabetes: 1 person, 5.88%
- Emotional Disorder: 1 person, 5.88%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%
- Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 5.88%
- Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Vx-950 and Neurontin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vx-950 and Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vx-950:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vx-950 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neurontin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on telaprevir and gabapentin (the active ingredients of Vx-950 and Neurontin, respectively), and Vx-950 and Neurontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Clemastine Fumarate and Zoledronic - 3 seconds ago
- Could Vivelle-Dot cause Pain? - 4 seconds ago
- Drug interactions of Nicotine and Hydrocortisone Butyrate - 6 seconds ago
- Could Relafen cause Fatigue? - 12 seconds ago
- Dizziness and Sinus Pain - 14 seconds ago
- Could Seroquel cause Dissociative Identity Disorder? - 16 seconds ago
- Could Depakote cause Dysthymia? - 19 seconds ago
- Drug interactions of Nicoderm Cq and Flexeril - 19 seconds ago
- Could Mobic cause Fainting? - 20 seconds ago
- Diarrhea and Furuncle - 27 seconds ago